Core Viewpoint - Dyadic International, Inc. is set to report its financial results for the second quarter of 2025 and will host a corporate update conference call on November 12, 2025 [1]. Company Overview - Dyadic Applied BioSolutions is a global biotechnology company that utilizes proprietary microbial platforms to produce recombinant proteins for various markets including life sciences, food and nutrition, and bio-industrial applications [4]. - The company’s C1 and Dapibus™ expression systems enable flexible, cost-effective manufacturing, forming the basis of a growing portfolio of commercial and partnered programs [4]. Conference Call Details - The conference call is scheduled for November 12, 2025, at 5:00 p.m. Eastern Time, with dial-in numbers provided for both toll-free and international participants [2]. - A webcast link for the conference call is available, and an archive will be accessible within 24 hours post-event [2]. Investor Relations - Questions for management during the Q&A session can be submitted via email prior to the conference call [3]. - For further information, the company’s website offers resources in the Investor Relations section [2][4].
Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025